OBJECTIVE: Vessels in brain arteriovenous malformations are prone to rupture. The underlying pathogenesis is not clear. Hereditary hemorrhagic telangiectasia type 2 patients with activin receptor-like kinase 1 (Alk1) mutation have a higher incidence of brain arteriovenous malformation than the general population. We tested the hypothesis that vascular endothelial growth factor impairs vascular integrity in the Alk1-deficient brain through reduction of mural cell coverage. METHODS AND RESULTS: Adult Alk1(1f/2f) mice (loxP sites flanking exons 4-6) and wild-type mice were injected with 2×10(7) PFU adenovious-cre recombinase and 2×10(9) genome copies of adeno-associated virus-vascular endothelial growth factor to induce focal homozygous Alk1 deletion (in Alk1(1f/2f) mice) and angiogenesis. Brain vessels were analyzed 8 weeks later. Compared with wild-type mice, the Alk1-deficient brain had more fibrin (99±30×10(3) pixels/mm(2) versus 40±13×10(3); P=0.001), iron deposition (508±506 pixels/mm(2) versus 6±49; P=0.04), and Iba1(+) microglia/macrophage infiltration (888±420 Iba1(+) cells/mm(2) versus 240±104 Iba1(+); P=0.001) after vascular endothelial growth factor stimulation. In the angiogenic foci, the Alk1-deficient brain had more α-smooth muscle actin negative vessels (52±9% versus 12±7%, P<0.001), fewer vascular-associated pericytes (503±179/mm(2) versus 931±115, P<0.001), and reduced platelet-derived growth factor receptor-β expression. CONCLUSIONS: Reduction of mural cell coverage in response to vascular endothelial growth factor stimulation is a potential mechanism for the impairment of vessel wall integrity in hereditary hemorrhagic telangiectasia type 2-associated brain arteriovenous malformation.
OBJECTIVE: Vessels in brain arteriovenous malformations are prone to rupture. The underlying pathogenesis is not clear. Hereditary hemorrhagic telangiectasia type 2patients with activin receptor-like kinase 1 (Alk1) mutation have a higher incidence of brain arteriovenous malformation than the general population. We tested the hypothesis that vascular endothelial growth factor impairs vascular integrity in the Alk1-deficient brain through reduction of mural cell coverage. METHODS AND RESULTS: Adult Alk1(1f/2f) mice (loxP sites flanking exons 4-6) and wild-type mice were injected with 2×10(7) PFU adenovious-cre recombinase and 2×10(9) genome copies of adeno-associated virus-vascular endothelial growth factor to induce focal homozygous Alk1 deletion (in Alk1(1f/2f) mice) and angiogenesis. Brain vessels were analyzed 8 weeks later. Compared with wild-type mice, the Alk1-deficient brain had more fibrin (99±30×10(3) pixels/mm(2) versus 40±13×10(3); P=0.001), iron deposition (508±506 pixels/mm(2) versus 6±49; P=0.04), and Iba1(+) microglia/macrophage infiltration (888±420 Iba1(+) cells/mm(2) versus 240±104 Iba1(+); P=0.001) after vascular endothelial growth factor stimulation. In the angiogenic foci, the Alk1-deficient brain had more α-smooth muscle actin negative vessels (52±9% versus 12±7%, P<0.001), fewer vascular-associated pericytes (503±179/mm(2) versus 931±115, P<0.001), and reduced platelet-derived growth factor receptor-β expression. CONCLUSIONS: Reduction of mural cell coverage in response to vascular endothelial growth factor stimulation is a potential mechanism for the impairment of vessel wall integrity in hereditary hemorrhagic telangiectasia type 2-associated brain arteriovenous malformation.
Authors: Yi Guo; Tara Saunders; Hua Su; Helen Kim; Deniz Akkoc; David A Saloner; Steven W Hetts; Christopher Hess; Michael T Lawton; Andrew W Bollen; Tony Pourmohamad; Charles E McCulloch; Tarik Tihan; William L Young Journal: Stroke Date: 2012-02-02 Impact factor: 7.914
Authors: Franck Lebrin; Samly Srun; Karine Raymond; Sabrina Martin; Stieneke van den Brink; Catarina Freitas; Christiane Bréant; Thomas Mathivet; Bruno Larrivée; Jean-Léon Thomas; Helen M Arthur; Cornelis J J Westermann; Frans Disch; Johannes J Mager; Repke J Snijder; Anne Eichmann; Christine L Mummery Journal: Nat Med Date: 2010-04-04 Impact factor: 53.440
Authors: Yongmei Chen; Wei Zhu; Andrew W Bollen; Michael T Lawton; Nicholas M Barbaro; Christopher F Dowd; Tomoki Hashimoto; Guo-Yuan Yang; William L Young Journal: Neurosurgery Date: 2008-06 Impact factor: 4.654
Authors: Helen Kim; Pirro G Hysi; Ludmila Pawlikowska; Annie Poon; Esteban González Burchard; Jonathan G Zaroff; Stephen Sidney; Nerissa U Ko; Achal S Achrol; Michael T Lawton; Charles E McCulloch; Pui-Yan Kwok; William L Young Journal: Cerebrovasc Dis Date: 2008-12-18 Impact factor: 2.762
Authors: Li Ma; Fanxia Shen; Kristine Jun; Chen Bao; Robert Kuo; William L Young; Stephen L Nishimura; Hua Su Journal: Transl Stroke Res Date: 2016-06-29 Impact factor: 6.829
Authors: Yi Guo; Tarik Tihan; Helen Kim; Christopher Hess; Michael T Lawton; William L Young; Yuanli Zhao; Hua Su Journal: Neuroimmunol Neuroinflamm Date: 2014
Authors: Rui Zhang; Zhenying Han; Vincent Degos; Fanxia Shen; Eun-Jung Choi; Zhengda Sun; Shuai Kang; Michael Wong; Wan Zhu; Lei Zhan; Helen M Arthur; S Paul Oh; Marie E Faughnan; Hua Su Journal: Angiogenesis Date: 2016-06-20 Impact factor: 9.596
Authors: Koji Ando; Weili Wang; Di Peng; Ayano Chiba; Anne K Lagendijk; Lindsey Barske; J Gage Crump; Didier Y R Stainier; Urban Lendahl; Katarzyna Koltowska; Benjamin M Hogan; Shigetomo Fukuhara; Naoki Mochizuki; Christer Betsholtz Journal: Development Date: 2019-01-25 Impact factor: 6.868